Jump to content

Bucumolol

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Bucumolol
Names
IUPAC name
8-[3-(tert-Butylamino)-2-hydroxypropoxy]-5-methylchromen-2-one
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
MeSH C024221
UNII
  • InChI=1S/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3
    Key: CIJVBYRUFLGDHY-UHFFFAOYSA-N
  • InChI=1/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3
    Key: CIJVBYRUFLGDHY-UHFFFAOYAD
  • CC1=C2C=CC(=O)OC2=C(C=C1)OCC(CNC(C)(C)C)O
Properties
C17H23NO4
Molar mass 305.374 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Bucumolol is a beta-adrenergic antagonist.[1]

References

  1. ^ Nakayama, K; Oshima, T; Koike, H (1981). "Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs". Archives Internationales de Pharmacodynamie et de Thérapie. 254 (1): 145–56. PMID 6121536.